IGC Pharma (IGC) Acquisitions (2011 - 2019)

IGC Pharma (IGC) has reported Acquisitions for 8 consecutive years, with $19000.0 the latest figure, recorded in Q3 2019.

• On a quarterly basis, Acquisitions rose 137.5% year-over-year to $19000.0 in Q3 2019; TTM through Sep 2019 was $55000.0, a 193.22% increase from a year earlier, with the FY2019 full-year figure at $45000.0, down 30.77% from the prior year.
• Acquisitions was $19000.0 for Q3 2019 at IGC Pharma, up from $4000.0 in the prior quarter.
• Over five years, Acquisitions peaked at $149000.0 in Q4 2017 and troughed at -$221000.0 in Q1 2018.
• A 5-year average of $146.17 and a median of $4500.0 in 2018 frame the typical range for Acquisitions.
• Across the five-year window, Acquisitions sank 3862.56% in 2016 and surged 137.5% in 2019, its largest moves.
• Over 5 years, Acquisitions stood at -$414.0 in 2015, then slumped by 3862.56% to -$16405.0 in 2016, then jumped by 1008.26% to $149000.0 in 2017, then tumbled by 80.54% to $29000.0 in 2018, then plunged by 34.48% to $19000.0 in 2019.
• The last three Acquisitions figures came in at $19000.0 (Q3 2019), $4000.0 (Q2 2019), and $3000.0 (Q1 2019), per Business Quant data.